Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocate for Prompt Vasculitis Diagnosis & Treatment

Carina Stanton  |  August 28, 2018

As experts who diagnose, treat and monitor complications of multisystem autoimmune diseases, rheumatologists are uniquely positioned to play a crucial role in caring and advocating for patients with vasculitis, according to Tanaz Kermani, MD, MS, a rheumatologist and director of the Vasculitis Program at UCLA in Los Angeles.

Vasculitis is a term for a group of rare diseases that include blood vessel inflammation.1 It “encompasses a number of rare conditions few physicians and specialists recognize—rheumatologists [among] them. These rapidly progressive conditions require prompt diagnosis and treatment to prevent devastating consequences for our patients,” Dr. Kermani says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She notes that because vasculitis patients often have involvement of multiple organ systems, it’s imperative a team of doctors work together closely as advocates for these patients.

Here are several important ways Dr. Kermani suggests rheumatologists advocate for vasculitis patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

1. Raise Awareness of Vasculitis Conditions
The conditions and issues faced by patients with vasculitis may not be clearly understood by physicians outside rheumatology, she cautions. Rheumatologists play an important role in the early detection of vasculitis and in ensuring appropriate work-up.

“Prompt diagnosis and treatment [are] the cornerstone to minimizing damage from vasculitis,” Dr. Kermani stresses.

Vasculitis symptoms can include vague symptoms, such as fatigue, fevers, weight loss, muscle pain, shortness of breath and cough; numbness or weakness in a hand or foot; and red skin spots, lumps or sores. The disease can also show no initial symptoms at all. Additionally, vasculitis can preferentially affect certain age groups. Examples: Kawasaki disease affects only children. IgA vasculitis (Henoch-Schönlein) is more common in children; meanwhile giant cell arteritis only affects adults over the age of 50.1

“The most important thing we can do is raise awareness of these signs and symptoms with other health professionals so they consider a vasculitis diagnosis and make a referral early,” Dr. Kermani says.

2. Support Vasculitis Patients & Families
By providing patients and their families with information when needed and directing them to reliable resources for support, rheumatologists can help patients feel less isolated, Dr. Kermani says. She directs her patients and their family members to the Vasculitis Foundation.

3. Influence Other Healthcare Professionals in a Meaningful Way
The ultimate goal from the advocacy perspective is to ensure better recognition of these conditions to enable earlier diagnosis and treatment. One way Dr. Kermani says rheumatologists can do this is by serving as the point person on a team of specialists caring for patients with these multisystem conditions. She says, “Referral to and collaborating with other specialists is very important to ensure the best outcomes for our vasculitis patients.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:Awarenesspatient advocacyVasculitis

Related Articles

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    May 12, 2022

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

    Large Vessel Vasculitis Outcome Measures: An Update from OMERACT

    March 19, 2019

    In ongoing work to validate data-driven outcome tools for clinical investigation in large vessel vasculitis, an international team of rheumatologists from the Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group has published a report on subclinical disease activity and patient perspectives on therapy response…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences